scispace - formally typeset
V

Vincent R. Bonagura

Researcher at Hofstra University

Publications -  159
Citations -  4450

Vincent R. Bonagura is an academic researcher from Hofstra University. The author has contributed to research in topics: Rheumatoid factor & Antibody. The author has an hindex of 39, co-authored 153 publications receiving 4043 citations. Previous affiliations of Vincent R. Bonagura include North Shore-LIJ Health System & The Feinstein Institute for Medical Research.

Papers
More filters
Journal ArticleDOI

Analysis of the pH Dependence of the Neonatal Fc Receptor/Immunoglobulin G Interaction Using Antibody and Receptor Variants

TL;DR: It is shown that the affinity of FcRn for IgG is reduced about 2 orders of magnitude as the pH is raised from 6.0 to 7.0, and it is demonstrated that IgG histidines located at the junction between the CH2 and CH3 domains contribute to the pH-dependent affinity transition.
Journal ArticleDOI

Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction.

TL;DR: The crystal structure of the Fab fragment of a patient-derived IgM rheumatoid factor complexed with human lgG4 Fc, at 3.2 Å resolution, is reported, which is the first structure of an autoantibody–autoantigen complex.
Journal ArticleDOI

Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection.

TL;DR: Parents of children with food allergy are more sensitive to the societal cost of their children’s food allergies than many people give them credit for, whereas schools mostly identified major needs for staff retraining and liability coverage if the system were to be introduced.
Journal ArticleDOI

Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus‐6 and ‐11

TL;DR: A complex defect in immune responsiveness to human papillomavirus‐6 and ‐11 is identified and this defect can be a cause for concern in patients with recurrent respiratory papilomatosis.
Journal ArticleDOI

Varicella-Zoster Virus Infection in Children with Underlying Human Immunodeficiency Virus Infection

TL;DR: It is predicted that immunization with live attenuated varicella vaccine is unlikely to be deleterious to HIV-infected children, but if they are immunized when they still have relatively normal levels of CD4+ lymphocytes, they may have a lower rate of reactivation of VZV than if they were allowed to develop natural varICElla when theirCD4+ cell counts have fallen to low levels as a result of progressive HIV infection.